» Articles » PMID: 32189611

Gaps Between Knowledge and Malaria Treatment Practices After Intensive Anti-Malaria Campaigns in Western Kenya: 2004-2016

Overview
Specialty Tropical Medicine
Date 2020 Mar 20
PMID 32189611
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Effective case management is central for malaria control, but not all of those affected by malaria have access to prompt, effective treatment. In Kenya, free malaria treatment has been implemented since 2006. However, questions remain regarding effective treatment. We conducted cross-sectional epidemiological and questionnaire surveys in four counties in western Kenya in 2004, 2010, and 2016, and antimalarial availability surveys in 2016. We found a significant decline in self-reported malaria cases and an improvement in knowledge of malaria prevention and treatment since 2004. Parasite prevalence declined significantly from 2004 to 2010; however, it has remained unchanged since then. Artemisinin-based combination therapies (ACTs) and sulfadoxine-pyrimethamine (SP) drugs were widely available everywhere. The proportion of ACT usage increased from none in 2004 to 48% and 69%, respectively, in 2010 and 2016, whereas SP drug usage declined from 88% in 2004 to 39% in 2010 and 27% in 2016. During the 2016 survey, non-intermittent preventive treatment in pregnancy use of SP was common (20.9% of all surveyed individual treatments). In 2004, 27.2% (168/617) of households sought hospital treatment alone, and this number increased to 50.6% in 2016. The key factors affecting treatment-seeking behavior were education level, wealth index, household size, and distance to hospitals. Our results indicated that gaps in malaria case management remain and out-of-policy treatment is still a concern.

Citing Articles

Perceptions and drivers of healthcare provider and drug dispenser practices for the treatment of malaria in pregnancy in the context of multiple first-line therapies in western Kenya: a qualitative study.

Osoro C, Dellicour S, Ochodo E, Young T, Kuile F, Gutman J Malar J. 2023; 22(1):274.

PMID: 37710229 PMC: 10503024. DOI: 10.1186/s12936-023-04698-w.


Healthcare provider and drug dispenser knowledge and adherence to guidelines for the case management of malaria in pregnancy in the context of multiple first-line artemisinin-based combination therapy in western Kenya.

Osoro C, Dellicour S, Ochodo E, Young T, Ter Kuile F, Gutman J Malar J. 2023; 22(1):262.

PMID: 37679753 PMC: 10486056. DOI: 10.1186/s12936-023-04692-2.


Irrigation-Induced Environmental Changes Sustain Malaria Transmission and Compromise Intervention Effectiveness.

Zhou G, Hemming-Schroeder E, Jeang B, Wang X, Zhong D, Lee M J Infect Dis. 2022; 226(9):1657-1666.

PMID: 36056912 PMC: 10205894. DOI: 10.1093/infdis/jiac361.


Efficacy of artemisinin-lumefantrine for treatment of uncomplicated malaria after more than a decade of its use in Kenya.

Kishoyian G, Njagi E, Orinda G, Kimani F, Thiongo K, Matoke-Muhia D Epidemiol Infect. 2021; 149:e27.

PMID: 33397548 PMC: 8057502. DOI: 10.1017/S0950268820003167.

References
1.
Smith N, Obala A, Simiyu C, Menya D, Khwa-Otsyula B, Prudhomme OMeara W . Accessibility, availability and affordability of anti-malarials in a rural district in Kenya after implementation of a national subsidy scheme. Malar J. 2011; 10:316. PMC: 3219795. DOI: 10.1186/1475-2875-10-316. View

2.
Dixit A, Lee M, Goettsch B, Afrane Y, Githeko A, Yan G . Discovering the cost of care: consumer, provider, and retailer surveys shed light on the determinants of malaria health-seeking behaviours. Malar J. 2016; 15:179. PMC: 4802645. DOI: 10.1186/s12936-016-1232-7. View

3.
Obonyo C, Ochieng F, Taylor W, Ochola S, Mugitu K, Olliaro P . Artesunate plus sulfadoxine-pyrimethamine for uncomplicated malaria in Kenyan children: a randomized, double-blind, placebo-controlled trial. Trans R Soc Trop Med Hyg. 2004; 97(5):585-91. DOI: 10.1016/s0035-9203(03)80038-x. View

4.
Abuya T, Mutemi W, Karisa B, Ochola S, Fegan G, Marsh V . Use of over-the-counter malaria medicines in children and adults in three districts in Kenya: implications for private medicine retailer interventions. Malar J. 2007; 6:57. PMC: 1872028. DOI: 10.1186/1475-2875-6-57. View

5.
Juma D, Omondi A, Ingasia L, Opot B, Cheruiyot A, Yeda R . Trends in drug resistance codons in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase genes in Kenyan parasites from 2008 to 2012. Malar J. 2014; 13:250. PMC: 4094641. DOI: 10.1186/1475-2875-13-250. View